KRAS G12C inhibitor 37

Modify Date: 2024-01-10 18:31:42

KRAS G12C inhibitor 37 structure	Common Name	KRAS G12C inhibitor 37
	CAS Number	2241720-04-5	Molecular Weight	660.73
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₃₅H₃₉F₃N₈O₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of KRAS G12C inhibitor 37

KRAS G12C inhibitor 37 is a potent inhibitor of KRAS G12C. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. KRAS G12C inhibitor 37 has the potential for the research of KRAS G12C-mediated cancer (extracted from patent WO2018143315A1, compound 65)[1].

Name	KRAS G12C inhibitor 37

Description	KRAS G12C inhibitor 37 is a potent inhibitor of KRAS G12C. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. KRAS G12C inhibitor 37 has the potential for the research of KRAS G12C-mediated cancer (extracted from patent WO2018143315A1, compound 65)[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> GPCR/G Protein >> Ras
References	[1]. Quinazoline compound. Patent WO2018143315A1.

Molecular Formula	C₃₅H₃₉F₃N₈O₂
Molecular Weight	660.73

KRAS G12C inhibitor 37

Use of KRAS G12C inhibitor 37

Names

KRAS G12C inhibitor 37 Biological Activity

Chemical & Physical Properties